These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32108672)

  • 21. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative.
    Hanna DB; Guo M; Bůžková P; Miller TL; Post WS; Stein JH; Currier JS; Kronmal RA; Freiberg MS; Bennett SN; Shikuma CM; Anastos K; Li Y; Tracy RP; Hodis HN; Delaney JA; Kaplan RC
    Clin Infect Dis; 2016 Jul; 63(2):249-56. PubMed ID: 27118787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study.
    Jung M; Parrinello CM; Xue X; Mack WJ; Anastos K; Lazar JM; Selzer RH; Shircore AM; Plankey M; Tien P; Cohen M; Gange SJ; Hodis HN; Kaplan RC
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25699995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohort.
    Lin H; Ding Y; Ning C; Qiao X; Chen X; Chen X; Shen W; Liu X; Hong Y; He N
    Lancet HIV; 2019 Dec; 6(12):e860-e868. PubMed ID: 31635991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus.
    Ramachandran S; Vinitha A; Kartha CC
    Cardiovasc Diabetol; 2016 Nov; 15(1):152. PubMed ID: 27809851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy.
    Calza L; Borderi M; Granozzi B; Malosso P; Pancaldi L; Bon I; Re MC
    HIV Res Clin Pract; 2019 Dec; 20(6):131-139. PubMed ID: 32065065
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection.
    O'Halloran JA; Dunne E; Gurwith M; Lambert JS; Sheehan GJ; Feeney ER; Pozniak A; Reiss P; Kenny D; Mallon P
    HIV Med; 2015 Nov; 16(10):608-19. PubMed ID: 26111187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals.
    Westhorpe CL; Maisa A; Spelman T; Hoy JF; Dewar EM; Karapanagiotidis S; Hearps AC; Cheng WJ; Trevillyan J; Lewin SR; Sviridov D; Elliott JH; Jaworowski A; Dart AM; Crowe SM
    Immunol Cell Biol; 2014 Feb; 92(2):133-8. PubMed ID: 24296810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased carotid intima-media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients.
    Goulenok T; Boyd A; Larsen M; Fastenackels S; Boccara F; Meynard JL; Hadour N; Samri A; Desvarieux M; Autran B; Appay V; Girard PM; Sauce D;
    AIDS; 2015 Jan; 29(3):287-93. PubMed ID: 25686677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of CXCR4 on non-classical monocytes in participants of the Women's Interagency HIV Study (WIHS) with subclinical atherosclerosis.
    Mueller KAL; Hanna DB; Ehinger E; Xue X; Baas L; Gawaz MP; Geisler T; Anastos K; Cohen MH; Gange SJ; Heath SL; Lazar JM; Liu C; Mack WJ; Ofotokun I; Tien PC; Hodis HN; Landay AL; Kaplan RC; Ley K
    Cardiovasc Res; 2019 May; 115(6):1029-1040. PubMed ID: 30520941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis.
    El-Far M; Durand M; Turcotte I; Larouche-Anctil E; Sylla M; Zaidan S; Chartrand-Lefebvre C; Bunet R; Ramani H; Sadouni M; Boldeanu I; Chamberland A; Lesage S; Baril JG; Trottier B; Thomas R; Gonzalez E; Filali-Mouhim A; Goulet JP; Martinson JA; Kassaye S; Karim R; Kizer JR; French AL; Gange SJ; Ancuta P; Routy JP; Hanna DB; Kaplan RC; Chomont N; Landay AL; Tremblay CL
    Front Immunol; 2021; 12():664371. PubMed ID: 33936102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression.
    D'Antoni ML; Mitchell BI; McCurdy S; Byron MM; Ogata-Arakaki D; Chow D; Mehta NN; Boisvert WA; Lefebvre E; Shikuma CM; Ndhlovu LC; Baumer Y
    J Leukoc Biol; 2018 Dec; 104(6):1241-1252. PubMed ID: 30088682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection.
    Kirichenko TV; Myasoedova VA; Shimonova TE; Melnichenko AA; Sviridov D; Sobenin IA; Mazus AI; Orekhov AN; Bukrinsky MI
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29961673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection.
    Novelli S; Lécuroux C; Goujard C; Reynes J; Villemant A; Blum L; Essat A; Avettand-Fenoël V; Launay O; Molina JM; Bourgeois C; Meyer L
    EBioMedicine; 2020 Dec; 62():103129. PubMed ID: 33248370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis.
    Haissman JM; Haugaard AK; Knudsen A; Kristoffersen US; Seljeflot I; Pedersen KK; Lebech AM; Hasbak P; Kjær A; Ostrowski SR; Gerstoft J; Trøseid M; Nielsen SD
    J Acquir Immune Defic Syndr; 2016 Dec; 73(5):507-513. PubMed ID: 27509250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection.
    Wiche Salinas TR; Zhang Y; Gosselin A; Rosario NF; El-Far M; Filali-Mouhim A; Routy JP; Chartrand-Lefebvre C; Landay AL; Durand M; Tremblay CL; Ancuta P;
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV-infected population (RHICCA): a protocol for a longitudinal cohort study.
    Peterson I; Ntsui N; Jambo K; Kelly C; Huwa J; Afran L; Tatuene JK; Pett S; Henrion MYR; Van Oosterhout J; Heyderman RS; Mwandumba H; Benjamin LA;
    BMJ Open; 2019 Sep; 9(9):e025576. PubMed ID: 31515413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and Inflammation.
    Steverson D; Tian L; Fu Y; Zhang W; Ma E; Garvey WT
    Metab Syndr Relat Disord; 2016 Feb; 14(1):7-15. PubMed ID: 26584255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.
    Siedner MJ; Kim JH; Nakku RS; Bibangambah P; Hemphill L; Triant VA; Haberer JE; Martin JN; Mocello AR; Boum Y; Kwon DS; Tracy RP; Burdo T; Huang Y; Cao H; Okello S; Bangsberg DR; Hunt PW
    J Infect Dis; 2016 Feb; 213(3):370-8. PubMed ID: 26347573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.
    Teer E; Joseph DE; Driescher N; Nell TA; Dominick L; Midgley N; Deshpande G; Page MJ; Pretorius E; Woudberg NJ; Lecour S; Glashoff RH; Essop MF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1146-H1157. PubMed ID: 30768357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.